Dynavax (DVAX) has provided an announcement.
Effective August 1, 2024, Dynavax Technologies Corporation welcomes back Kelly MacDonald as Chief Financial Officer after her maternity leave, with CEO Ryan Spencer resuming his sole role after covering as Interim CFO. MacDonald’s re-appointment carries no changes to her compensation, and her background details can be found in the Company’s recent proxy statement.
For an in-depth examination of DVAX stock, go to TipRanks’ Stock Analysis page.